These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 32211328)

  • 1. Editorial: The Role of Breast Cancer Stem Cells in Clinical Outcomes.
    Raman D; Tiwari AK; Tiriveedhi V; Rhoades Sterling JA
    Front Oncol; 2020; 10():299. PubMed ID: 32211328
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of Breast Cancer Stem Cells and Intratumor Stemness Heterogeneity in Triple-negative Breast Cancer as Prognostic Factors.
    Yang F; Cao L; Sun Z; Jin J; Fang H; Zhang W; Guan X
    Int J Biol Sci; 2016; 12(12):1568-1577. PubMed ID: 27994520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneity and Plasticity of Breast Cancer Stem Cells.
    Sousa B; Ribeiro AS; Paredes J
    Adv Exp Med Biol; 2019; 1139():83-103. PubMed ID: 31134496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokines, breast cancer stem cells (BCSCs) and chemoresistance.
    Chen W; Qin Y; Liu S
    Clin Transl Med; 2018 Sep; 7(1):27. PubMed ID: 30175384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-200c/141 Regulates Breast Cancer Stem Cell Heterogeneity via Targeting HIPK1/β-Catenin Axis.
    Liu B; Du R; Zhou L; Xu J; Chen S; Chen J; Yang X; Liu DX; Shao ZM; Zhang L; Yu Z; Xie N; Guan JL; Liu S
    Theranostics; 2018; 8(21):5801-5813. PubMed ID: 30613263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer stemness in bone marrow micrometastases of human breast cancer.
    Kuo MC; Kothari AN; Kuo PC; Mi Z
    Surgery; 2018 Feb; 163(2):330-335. PubMed ID: 28988933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of tumor microenvironment in cancer stem cell chemoresistance and recurrence.
    Das M; Law S
    Int J Biochem Cell Biol; 2018 Oct; 103():115-124. PubMed ID: 30153480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer stem cells in solid and liquid tissues of breast cancer patients: characterization and therapeutic perspectives.
    Chiotaki R; Polioudaki H; Theodoropoulos PA
    Curr Cancer Drug Targets; 2015; 15(3):256-69. PubMed ID: 25669721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast Cancer Stem Cells as Drivers of Tumor Chemoresistance, Dormancy and Relapse: New Challenges and Therapeutic Opportunities.
    De Angelis ML; Francescangeli F; Zeuner A
    Cancers (Basel); 2019 Oct; 11(10):. PubMed ID: 31619007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoparticle Delivery of miR-34a Eradicates Long-term-cultured Breast Cancer Stem Cells via Targeting C22ORF28 Directly.
    Lin X; Chen W; Wei F; Zhou BP; Hung MC; Xie X
    Theranostics; 2017; 7(19):4805-4824. PubMed ID: 29187905
    [No Abstract]   [Full Text] [Related]  

  • 11. Oral Cancer Stem Cells Microenvironment.
    Naik PP; Panda PK; Bhutia SK
    Adv Exp Med Biol; 2017; 1041():207-233. PubMed ID: 29204835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting specificity of dendritic cells on breast cancer stem cells: in vitro and in vivo evaluations.
    Nguyen ST; Nguyen HL; Pham VQ; Nguyen GT; Tran CD; Phan NK; Pham PV
    Onco Targets Ther; 2015; 8():323-34. PubMed ID: 25674007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling of Cancer Stem Cell State Transitions Predicts Therapeutic Response.
    Sehl ME; Shimada M; Landeros A; Lange K; Wicha MS
    PLoS One; 2015; 10(9):e0135797. PubMed ID: 26397099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carcinoma-associated fibroblasts promote the stemness and chemoresistance of colorectal cancer by transferring exosomal lncRNA H19.
    Ren J; Ding L; Zhang D; Shi G; Xu Q; Shen S; Wang Y; Wang T; Hou Y
    Theranostics; 2018; 8(14):3932-3948. PubMed ID: 30083271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autophagy Differentially Regulates Distinct Breast Cancer Stem-like Cells in Murine Models via EGFR/Stat3 and Tgfβ/Smad Signaling.
    Yeo SK; Wen J; Chen S; Guan JL
    Cancer Res; 2016 Jun; 76(11):3397-410. PubMed ID: 27197172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-873/PD-L1 axis regulates the stemness of breast cancer cells.
    Gao L; Guo Q; Li X; Yang X; Ni H; Wang T; Zhao Q; Liu H; Xing Y; Xi T; Zheng L
    EBioMedicine; 2019 Mar; 41():395-407. PubMed ID: 30803931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular matrix-mediated regulation of cancer stem cells and chemoresistance.
    Brown Y; Hua S; Tanwar PS
    Int J Biochem Cell Biol; 2019 Apr; 109():90-104. PubMed ID: 30743057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PAF-Wnt signaling-induced cell plasticity is required for maintenance of breast cancer cell stemness.
    Wang X; Jung YS; Jun S; Lee S; Wang W; Schneider A; Sun Oh Y; Lin SH; Park BJ; Chen J; Keyomarsi K; Park JI
    Nat Commun; 2016 Feb; 7():10633. PubMed ID: 26843124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells.
    Tong M; Deng Z; Yang M; Xu C; Zhang X; Zhang Q; Liao Y; Deng X; Lv D; Zhang X; Zhang Y; Li P; Song L; Wang B; Al-Dherasi A; Li Z; Liu Q
    Cancer Commun (Lond); 2018 Sep; 38(1):56. PubMed ID: 30231942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. POMC maintains tumor-initiating properties of tumor tissue-derived long-term-cultured breast cancer stem cells.
    Lin X; Chen W; Wei F; Zhou BP; Hung MC; Xie X
    Int J Cancer; 2017 Jun; 140(11):2517-2525. PubMed ID: 28214331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.